Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$112.67 - $176.92 $2.85 Million - $4.47 Million
-25,258 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$121.62 - $145.29 $9.5 Million - $11.3 Million
-78,118 Reduced 75.57%
25,258 $3.32 Million
Q1 2021

May 14, 2021

SELL
$124.92 - $173.33 $1.84 Million - $2.56 Million
-14,745 Reduced 12.48%
103,376 $13.3 Million
Q4 2020

Feb 02, 2021

BUY
$151.2 - $182.76 $2.79 Million - $3.37 Million
18,441 Added 18.5%
118,121 $19.7 Million
Q3 2020

Nov 05, 2020

BUY
$134.29 - $154.32 $1.48 Million - $1.7 Million
11,002 Added 12.41%
99,680 $15.4 Million
Q2 2020

Aug 12, 2020

BUY
$110.87 - $156.01 $3.82 Million - $5.38 Million
34,478 Added 63.61%
88,678 $13.1 Million
Q1 2020

May 12, 2020

BUY
$97.01 - $145.11 $38,804 - $58,044
400 Added 0.74%
54,200 $6.1 Million
Q4 2019

Jan 27, 2020

BUY
$91.45 - $139.12 $978,515 - $1.49 Million
10,700 Added 24.83%
53,800 $7.49 Million
Q3 2019

Oct 31, 2019

BUY
$95.8 - $118.9 $1.77 Million - $2.2 Million
18,500 Added 75.2%
43,100 $4.15 Million
Q2 2019

Aug 15, 2019

SELL
$107.11 - $132.09 $275,808 - $340,131
-2,575 Reduced 9.48%
24,600 $2.83 Million
Q1 2019

May 03, 2019

SELL
$62.15 - $129.99 $995,456 - $2.08 Million
-16,017 Reduced 37.08%
27,175 $3.2 Million
Q4 2018

Feb 08, 2019

SELL
$55.16 - $69.67 $115,836 - $146,307
-2,100 Reduced 4.64%
43,192 $2.71 Million
Q3 2018

Nov 13, 2018

BUY
$63.77 - $76.28 $1.08 Million - $1.3 Million
17,011 Added 60.15%
45,292 $3.21 Million
Q2 2018

Aug 15, 2018

SELL
$58.55 - $73.92 $935,277 - $1.18 Million
-15,974 Reduced 36.1%
28,281 $1.88 Million
Q1 2018

May 11, 2018

BUY
$38.98 - $68.04 $936,299 - $1.63 Million
24,020 Added 118.71%
44,255 $2.89 Million
Q4 2017

Feb 06, 2018

BUY
$31.98 - $40.38 $18,452 - $23,299
577 Added 2.94%
20,235 $811,000
Q3 2017

Nov 15, 2017

BUY
$26.89 - $37.1 $528,603 - $729,311
19,658
19,658 $713,000

Others Institutions Holding ASND

About Ascendis Pharma A/S


  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $8.89B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.